Trade Related Aspects of Intellectual Property Rights (TRIPS)
COVID-19 vaccine: Who holds intellectual property rights?

Immunologist Dr. Satyajit Rath and Newsclick’s Prabir Purkayastha talk about the recent debates on the intellectual property rights on vaccines and the possibilities of mass immunization

Palestinian boy killed during Israeli raids in the Occupied Territories and other stories

Today we look at the killing of a Palestinian boy in a raid by Israeli forces, protests against femicides in Puerto Rico, and more

Under mounting pressure, US agrees to support limited IP waiver for COVID-19 vaccine; others follow

Shortly after the US announced that it will support a limited TRIPS waiver for COVID-19 vaccines, the European Union announced that it was open to discussions. However, the approval of the proposal at the World Trade Organization might take longer

Explained: How Intellectual Property Rights are blocking vaccine production

What is standing in the way of expanding production and carrying out mass vaccination campaigns across the world?

How pharma companies created a bottleneck in vaccine distribution

Private pharma companies and developed nations have created a bottleneck in vaccine distribution through the use of patents and legislation

Lack of political will and IPR rules stand in the way of mass vaccination for COVID-19

A proposal made by India and South Africa in October last year to waive certain Intellectual Property Rights (IPR) of COVID vaccines has gained massive support across the world. Despite its potential to prevent millions of avoidable deaths, the US and its allies continue to block the proposal at the WTO.

Demand for waving patent rights to produce COVID-19 vaccines gains momentum

WTO’s TRIPS agreements have limited the production of COVID-19 vaccines leading to unequal access globally where some rich countries have amassed more than required doses and majority of poor countries have received none or inadequate number of doses

    × To Subscribe